Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Total Voting Rights

1 Jun 2022 13:00

RNS Number : 5903N
Ideagen PLC
01 June 2022
 

1 June 2022

Ideagen PLC

 

("Ideagen," "the Company" or the "Group'')

Total Voting Rights

In line with the Financial Conduct Authority's Disclosure and Transparency Rules, Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that as at today's date, the Company's total issued share capital is 293,853,523 ordinary shares of 1p each ("Ordinary Shares") and the total number of voting rights will therefore be 293,853,523.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

 Ideagen plc

01629 699 100

Ben Dorks, Chief Executive Officer

Emma Hayes, Chief Financial Officer

 

Canaccord Genuity Limited (Nomad)

020 7523 8000

Simon Bridges

 

Georgina McCooke

 

 

 

 

 

Numis Securities Limited

0207 260 1267

Simon Willis

 

Joshua Hughes

 

 

 

FTI Consulting

020 3727 1000

Jamie Ricketts

ideagen@fticonsulting.com

Dwight Burden

Valerija Cymbal

 

About Ideagen plc

Ideagen's software helps companies comply with regulation and manage risk.

Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance. 

More than 10,000 customers use Ideagen's software, including leading accounting and pharmaceutical firms.

Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, Aggreko, Bank of New York and Johnson Matthey.

Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, USA, Middle East and South East Asia. For further information please visit www.ideagen.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFBMBTMTJMBMT
Date   Source Headline
1st Jun 202211:45 amRNSForm 8.5 (EPT/RI)
1st Jun 202211:04 amRNSForm 8.3 - Ideagen plc
1st Jun 202211:00 amRNSForm 8.3 - Ideagen Plc
1st Jun 202210:20 amRNSForm 8.3 - IDEAGEN PLC
1st Jun 202210:17 amGNWForm 8.3 - Ideagen PLC
31st May 20223:29 pmRNSForm 8.5 (EPT/RI)- Amendment
31st May 20223:15 pmBUSForm 8.3 - Ideagen plc
31st May 20223:03 pmRNSForm 8.3 - Ideagen plc
31st May 202212:12 pmRNSForm 8.3 - Ideagen plc
31st May 202211:10 amRNSForm 8.5 (EPT/RI)
31st May 202211:04 amBUSForm 8.3 - IDEAGEN PLC
31st May 20229:59 amRNSForm 8.3 - Ideagen plc
31st May 20229:55 amGNWForm 8.3 - Ideagen PLC
30th May 20224:45 pmRNSDirector/PDMR Shareholding
30th May 20224:01 pmBUSForm 8.3 - Ideagen plc
30th May 20223:30 pmRNSHolding(s) in Company
30th May 20223:00 pmBUSForm 8.3 - IDEA LN
30th May 20222:47 pmRNSForm 8.3 - Ideagen Plc
30th May 20221:01 pmGNWForm 8.3 - [Ideagen plc - 27 05 2022] - (CGWL)
30th May 202212:29 pmRNSForm 8.3 - Ideagen plc
30th May 202212:16 pmGNWForm 8.3 - Ideagen PLC
30th May 202212:09 pmRNSForm 8.3 - Ideagen plc
30th May 202211:15 amRNSPublication of Scheme Document
30th May 202211:09 amRNSForm 8.5 (EPT/RI)
30th May 202211:02 amRNSForm 8.5 (EPT/RI)
30th May 202210:29 amGNWForm 8.3 - Ideagen Plc
30th May 202210:04 amRNSForm 8.3 - Ideagen PLC
30th May 20227:07 amRNSForm 8.5 (EPT/RI) - Amendment
27th May 20223:20 pmRNSForm 8.3 - Ideagen plc
27th May 20223:15 pmBUSForm 8.3 - Ideagen plc
27th May 20222:35 pmRNSForm 8.3 - Ideagen PLC
27th May 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
27th May 202212:15 pmRNSForm 8.3 - Ideagen plc
27th May 202211:59 amGNWForm 8.3 - [IDEAGEN PLC - 26 05 2022] - CGWL
27th May 202211:43 amRNSForm 8.3 - Ideagen plc
27th May 202211:34 amRNSForm 8.5 (EPT/RI)
27th May 202210:43 amRNSForm 8.3 - Ideagen plc
27th May 202210:42 amGNWForm 8.3 - Ideagen PLC
27th May 202210:00 amGNWForm 8.3 - Ideagen PLC
26th May 20223:20 pmRNSForm 8.3 - Ideagen plc
26th May 20223:15 pmBUSForm 8.3 - Ideagen plc
26th May 20221:15 pmRNSForm 8.3 - Ideagen plc
26th May 202212:29 pmRNSForm 8.3 - Ideagen plc
26th May 202212:10 pmGNWForm 8.3 - [IDEAGEN PLC - 25 05 2022] - CGWL
26th May 202211:38 amRNSForm 8.3 - Ideagen Plc
26th May 202211:06 amRNSForm 8.5 (EPT/RI)
26th May 202210:49 amGNWForm 8.3 - Ideagen PLC
26th May 202210:31 amRNSRule 2.9 Announcement
26th May 202210:30 amRNSIssue of Equity and TVR
26th May 20229:57 amRNSForm 8.3 - Ideagen Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.